Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical study evaluating the safety, tolerability, and preliminary efficacy of [225Ac]Ac-PSMA-XT Injection in metastatic castrat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• [225Ac]Ac-PSMA-XT Injection (Actinium-225 labeled PSMA-XT injection)

Snippet

Sponsor: Xiaorong Sun | Conditions: Metastatic Castration-Resistant Prostate Cancer Patients | Phase 1 | Status: RECRUITING